Bode John B — SEC insider filings
SEC reporting owner CIK 1612084. 15 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2020-10-14 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 10 legs across 5 filings — 45,000 shares, $285,861 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: purchase of 10,000 shares @ $7.96 ($79,624) in ZEVRA THERAPEUTICS, INC., filed 2025-03-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. (ZVRA) | Director | 9 | 10 legs · 45,000 sh · $285,861 | — | 7 |
| FISION Corp (FSSN) | Director | 3 | — | — | 10 |
| Newton Golf Company, Inc. (NWTG) | Director | 1 | — | — | 1 |
| SPAR Group, Inc. (SGRP) | Director | 1 | — | — | 1 |
| Stewards, Inc. (SWRD) | Director | 1 | — | — | — |
Insider filings — Bode John B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | SPAR Group, Inc. (SGRP) | Grant/award (A): 110,000 | EDGAR |
| 2026-09-21 | 3 | Stewards, Inc. (SWRD) | Holdings only — no transactions reported | EDGAR |
| 2026-03-26 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 39,200 @ $4.97 · Option exercise (M): 39,200 @ $4.89 · Option exercise (M): 39,200 (derivative) @ $0 · Option exercise (M): 39,200 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Newton Golf Company, Inc. (NWTG) | Grant/award (A): 18,549 @ $0 | EDGAR |
| 2025-08-20 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase (P): 5,000 @ $9.16 | EDGAR |
| 2025-05-30 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase (P): 10,000 @ $7.96 | EDGAR |
| 2024-07-15 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase (P): 10,000 @ $5.87 | EDGAR |
| 2024-05-15 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 39,200 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase (P): 10,000 @ $5.13 | EDGAR |
| 2023-05-19 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase (P): 1,390 @ $5.04 · Purchase (P): 300 @ $5.04 · Purchase (P): 1,000 @ $5.04 · Purchase (P): 4,759 @ $5.04 · Purchase (P): 100 @ $5.04 · Purchase (P): 2,451 @ $5.05 | EDGAR |
| 2023-05-08 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 58,800 (derivative) @ $0 | EDGAR |
| 2021-12-28 | 4 | FISION Corp (FSSN) | Grant/award (A): 396,825 @ $0.03 · Grant/award (A): 592,417 @ $0.02 · Grant/award (A): 502,008 @ $0.02 | EDGAR |
| 2021-04-19 | 4 | FISION Corp (FSSN) | Grant/award (A): 1,420,455 @ $0.01 · Grant/award (A): 459,559 @ $0.03 | EDGAR |
| 2020-10-14 | 4 | FISION Corp (FSSN) | Grant/award (A): 490,196 @ $0.03 · Grant/award (A): 781,250 @ $0.02 · Grant/award (A): 2,083,333 @ $0.01 · Grant/award (A): 2,604,167 @ $0.00 · Grant/award (A): 675,676 @ $0.02 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1612084 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs